---
$id: https://graph.org.ai/products/commodity/51271612
$type: Product
source: UNSPSC
code: "51271612"
title: "Levobupivacaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levobupivacaine

**UNSPSC Code**: 51271612
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C18H28N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A5H73K9U3W, chemically known as 2,6-pipecoloxylidide, 1-butyl-, l-(-)- but generally known as levobupivacaine, which bears US NIH Compound Identifier 92253. European Medicines Agency schedules Levobupivacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08464MIG. The term LEVOBUPIVACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). World Health Organization schedules levobupivacaine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, LEVOBUPIVACAINE remains the US FDA Preferred Term for this commodity. Levobupivacaine bears US NLM identifiers UMLS ID C0873118 and NCI Concept Code C87594. SMILES: O=C(NC1C(CCCC1C)C)C1N(CCCC1)CCCC.

